Ritu Lal, Ph.D.

“Consuelo and the entire team at SV Latam Capital have been our strong champions, collaborators, and partners. SV Latam invested in GEn1E Lifesciences in 2019 and have been our consistent supporters and evangelists. They have helped us to achieve warp speed with maximum cost efficiency for bringing medicines to patients with rare inflammatory diseases, a huge unmet need and a $100B+ market size. The decision analysis process as a part of their diligence by SV Latam was an extremely useful exercise for us to think through the commercial milestones and value inflections points throughout our roadmap. In a nutshell, SV Latam is a dream partner for any passionate entrepreneur.”